1. Home
  2. USNA vs BVS Comparison

USNA vs BVS Comparison

Compare USNA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • BVS
  • Stock Information
  • Founded
  • USNA 1992
  • BVS 2011
  • Country
  • USNA United States
  • BVS United States
  • Employees
  • USNA N/A
  • BVS N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • USNA Health Care
  • BVS Health Care
  • Exchange
  • USNA Nasdaq
  • BVS Nasdaq
  • Market Cap
  • USNA 541.4M
  • BVS 496.7M
  • IPO Year
  • USNA 1996
  • BVS 2021
  • Fundamental
  • Price
  • USNA $30.54
  • BVS $6.46
  • Analyst Decision
  • USNA Hold
  • BVS Strong Buy
  • Analyst Count
  • USNA 1
  • BVS 4
  • Target Price
  • USNA $36.00
  • BVS $15.00
  • AVG Volume (30 Days)
  • USNA 143.4K
  • BVS 325.5K
  • Earning Date
  • USNA 07-22-2025
  • BVS 08-05-2025
  • Dividend Yield
  • USNA N/A
  • BVS N/A
  • EPS Growth
  • USNA N/A
  • BVS N/A
  • EPS
  • USNA 1.82
  • BVS N/A
  • Revenue
  • USNA $876,242,000.00
  • BVS $567,699,000.00
  • Revenue This Year
  • USNA $13.04
  • BVS N/A
  • Revenue Next Year
  • USNA $7.36
  • BVS $6.11
  • P/E Ratio
  • USNA $16.81
  • BVS N/A
  • Revenue Growth
  • USNA N/A
  • BVS 8.60
  • 52 Week Low
  • USNA $23.10
  • BVS $5.28
  • 52 Week High
  • USNA $48.85
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • USNA 56.70
  • BVS 43.37
  • Support Level
  • USNA $29.29
  • BVS $6.32
  • Resistance Level
  • USNA $31.20
  • BVS $7.08
  • Average True Range (ATR)
  • USNA 0.74
  • BVS 0.23
  • MACD
  • USNA -0.00
  • BVS 0.02
  • Stochastic Oscillator
  • USNA 71.05
  • BVS 25.00

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: